Beck Mack & Oliver’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.6M Sell
207,122
-7,032
-3% -$1.64M 1.03% 30
2026
Q1
$52.3M Sell
214,154
-5,540
-3% -$1.29M 1.08% 26
2025
Q4
$45.5M Sell
219,694
-1,226
-0.6% -$242K 0.83% 34
2025
Q3
$41M Sell
220,920
-6,035
-3% -$1.03M 0.75% 33
2025
Q2
$34.7M Sell
226,955
-3,325
-1% -$511K 0.66% 34
2025
Q1
$38.2M Sell
230,280
-19,592
-8% -$3.07M 0.76% 32
2024
Q4
$36.1M Sell
249,872
-628
-0.3% -$97.3K 0.67% 37
2024
Q3
$40.6M Sell
250,500
-4,105
-2% -$654K 0.79% 35
2024
Q2
$37.2M Sell
254,605
-11,837
-4% -$1.76M 0.77% 35
2024
Q1
$42.1M Sell
266,442
-6,942
-3% -$1.1M 0.85% 35
2023
Q4
$42.9M Buy
273,384
+70
+0% +$10.7K 1% 33
2023
Q3
$42.6M Sell
273,314
-4,919
-2% -$812K 1.11% 32
2023
Q2
$46.1M Sell
278,233
-1,997
-0.7% -$322K 1.2% 31
2023
Q1
$43.4M Sell
280,230
-4,752
-2% -$767K 1.25% 32
2022
Q4
$50.3M Sell
284,982
-3,397
-1% -$587K 1.48% 24
2022
Q3
$47.1M Sell
288,379
-3,541
-1% -$599K 1.52% 25
2022
Q2
$51.8M Sell
291,920
-2,121
-0.7% -$378K 1.55% 22
2022
Q1
$52.1M Sell
294,041
-10,463
-3% -$1.78M 1.31% 28
2021
Q4
$52.1M Sell
304,504
-7,539
-2% -$1.23M 1.24% 28
2021
Q3
$50.4M Buy
312,043
+1,779
+0.6% +$304K 1.31% 30
2021
Q2
$51.1M Buy
310,264
+19,243
+7% +$3.19M 1.36% 29
2021
Q1
$47.8M Sell
291,021
-29,160
-9% -$4.72M 1.48% 26
2020
Q4
$50.4M Sell
320,181
-13,882
-4% -$2.05M 1.67% 22
2020
Q3
$49.7M Sell
334,063
-3,090
-0.9% -$457K 1.83% 18
2020
Q2
$47.4M Sell
337,153
-2,435
-0.7% -$355K 1.76% 19
2020
Q1
$44.5M Sell
339,588
-8,424
-2% -$1.2M 1.98% 16
2019
Q4
$50.8M Sell
348,012
-8,340
-2% -$1.13M 1.68% 21
2019
Q3
$46.1M Sell
356,352
-9,085
-2% -$1.2M 1.62% 23
2019
Q2
$50.9M Sell
365,437
-4,412
-1% -$611K 1.79% 19
2019
Q1
$51.7M Sell
369,849
-5,864
-2% -$785K 1.85% 20
2018
Q4
$48.5M Sell
375,713
-15,407
-4% -$2.15M 1.95% 20
2018
Q3
$54M Sell
391,120
-14,253
-4% -$1.89M 1.72% 20
2018
Q2
$49.2M Sell
405,373
-12,070
-3% -$1.51M 1.65% 23
2018
Q1
$53.5M Sell
417,443
-12,383
-3% -$1.67M 1.8% 22
2017
Q4
$60.1M Sell
429,826
-35,565
-8% -$4.95M 1.97% 19
2017
Q3
$60.5M Sell
465,391
-29,324
-6% -$3.89M 1.99% 19
2017
Q2
$65.4M Sell
494,715
-9,372
-2% -$1.2M 2.2% 16
2017
Q1
$62.8M Sell
504,087
-8,119
-2% -$970K 2.2% 17
2016
Q4
$59M Sell
512,206
-12,977
-2% -$1.5M 2.12% 18
2016
Q3
$62M Sell
525,183
-26,212
-5% -$3.18M 2.24% 17
2016
Q2
$66.9M Sell
551,395
-21,315
-4% -$2.42M 2.36% 12
2016
Q1
$62M Sell
572,710
-28,101
-5% -$2.91M 2.16% 17
2015
Q4
$61.7M Sell
600,811
-67,361
-10% -$6.77M 2.1% 17
2015
Q3
$62.4M Sell
668,172
-54,441
-8% -$5.27M 1.89% 19
2015
Q2
$70.4M Sell
722,613
-38,185
-5% -$3.82M 1.84% 21
2015
Q1
$76.5M Sell
760,798
-19,762
-3% -$2.01M 1.92% 19
2014
Q4
$81.6M Sell
780,560
-56,489
-7% -$5.95M 1.98% 17
2014
Q3
$89.2M Sell
837,049
-9,708
-1% -$1.01M 2.1% 14
2014
Q2
$88.6M Sell
846,757
-29,715
-3% -$3M 1.99% 18
2014
Q1
$86.1M Sell
876,472
-47,816
-5% -$4.43M 2.01% 19
2013
Q4
$84.7M Sell
924,288
-34,157
-4% -$3.15M 2.07% 17
2013
Q3
$83.1M Sell
958,445
-52,116
-5% -$4.68M 2.19% 18
2013
Q2
$86.8M Buy
+1,010,561
New +$85.8M 2.37% 13

Other funds holding JNJ

Beck Mack & Oliver's JNJ Position: Q2 2026 in Review

Beck Mack & Oliver reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q2 2026, selling an estimated $1.64M and leaving 207,122 shares worth $52.6M. The position accounts for 1.03% of the portfolio, ranked #30.

Beck Mack & Oliver first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $89.2M in Q3 2014. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Beck Mack & Oliver held 207,122 shares of Johnson & Johnson worth $52.6M as of Q2 2026.
  • Beck Mack & Oliver sold 7,032 Johnson & Johnson shares in Q2 2026, an estimated $1.64M.
  • Johnson & Johnson made up 1.03% of Beck Mack & Oliver's portfolio in Q2 2026, its #30 holding.
  • Beck Mack & Oliver first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Beck Mack & Oliver's Johnson & Johnson position peaked at $89.2M in Q3 2014.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.